Classification and management of cervical paragangliomas

Annals of the Royal College of Surgeons of England

Volumn 93, Issue 8, 2011, Pages 596-602

  Obholzer, R J ^a   Hornigold, R ^a   Connor, S ^a   Gleeson, M J ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Carotid artery; Classification; Glomus tumour; Paraganglioma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLASSIFICATION; FACE PAIN; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; PARAGANGLIOMA; PARALYSIS; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FACIAL PAIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PARAGANGLIOMA; PARALYSIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84555203665     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/147870811X13137608455172     Document Type: Article

References (23)

1. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002; 39; 617-622.
2. Zak FG, Lawson W. The Paraganglionic Chemoreceptor System: Physiology, Pathology and Clinical Medicine. New York: Springer; 1982.
3. Hinerman RW, Amdur RJ, Morris CG et al. Definitive radiotherapy in the management of paragangliomas arising in the head and neck: a 35-year experience. Head Neck 2008; 30: 1,431-1,438.
4. Navarro Martín A, Maitz A, Grills IS et al. Successful treatment of glomus jugulare tumours with gamma knife radiosurgery: clinical and physical aspects of management and review of the literature. Clin Transl Oncol 2010; 12: 55-62.
5. Nora JD, Hallett JW, O'Brien PC et al. Surgical resection of carotid body tumors: long-term survival, recurrence, and metastasis. Mayo Clin Proc 1988; 63: 348-352.
6. van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ et al. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989; 2: 1,291-1,294.
7. Oldring D, Fisch U. Glomus tumors of the temporal region: surgical therapy. Am J Otol 1979; 1: 7-18.
8. Fisch U, Fagan P, Valavanis A. The infratemporal fossa approach for the lateral skull base. Otolaryngol Clin North Am 1984; 17: 513-552.
9. Wen HT, Rhoton AL, Katsuta T, de Oliveira E. Microsurgical anatomy of the transcondylar, supracondylar, and paracondylar extensions of the far-lateral approach. J Neurosurg 1997; 87: 555-585.
10. Spektor S, Anderson GJ, McMenomey SO et al. Quantitative description of the far-lateral transcondylar transtubercular approach to the foramen magnum and clivus. J Neurosurg 2000; 92: 824-831.
11. Schipper J, Spetzger U, Tatagiba M et al. Juxtacondylar approach in temporal paraganglioma surgery: when and why? Skull Base 2009; 19: 43-47.
12. World health Organization. Pathology and Genetics: Tumours of Endocrine Organs. Lyon, France: IARC; 2004.
13. Elders RA. Paraganglioma [PhD dissertation]. Groningen, Netherlands: University of Groningen; 1962.
14. Stoeckli SJ, Schuknecht B, Alkadhi H, Fisch U. Evaluation of paragangliomas presenting as a cervical mass on color-coded Doppler sonography. Laryngoscope 2002; 112: 143-146.
15. Shamblin WR, ReMine Wh, Sheps SG, harrison EG. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg 1971; 122: 732-739.
16. Arya S, Rao V, Juvekar S, Dcruz AK. Carotid body tumors: objective criteria to predict the Shamblin group on MR imaging. Am J Neuroradiol 2008; 29: 1,349-1,354.
17. Kollert M, Minovi AA, Draf W, Bockmühl U. Cervical paragangliomas-tumor control and long-term functional results after surgery. Skull Base 2006; 16: 185-191.
18. Drovdlic CM, Myers EN, Peters JA et al. Proportion of heritable paraganglioma cases and associated clinical characteristics. Laryngoscope 2001; 111: 1,822-1,827.
19. Neumayer C, Moritz A, Asari R et al. Novel SDhD germ-line mutations in pheochromocytoma patients. Eur J Clin Invest 2007; 37: 544-551.
20. Telischi FF, Bustillo A, Whiteman ML et al. Octreotide scintigraphy for the detection of paragangliomas. Otolaryngol Head Neck Surg 2000; 122: 358-362.
21. Taïeb D, Sebag F, Hubbard JG et al. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? Clin Endocrinol 2004; 61: 102-108.
22. Neumann HP, Berger DP, Sigmund G et al. Phaeochromocytomas, multiple endocrine neoplasia type 2, and von hippel-Lindau disease. N Engl J Med 1993; 329: 1,531-1,538.
23. DeAngelis LM, Kelleher MB, Post KD, Fetell MR. Multiple paragangliomas in neurofibromatosis: a new neuroendocrine neoplasia. Neurology 1987; 37: 129-133.